GlassScriptPhysician profile
Diana Passwaters
NPI 1770631996
$2,666.81
in general payments reported to CMS, 2019-2025
17 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2022: $141 · 2023: $262 · 2024: $998 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $452.78 | 2021-2024 | Airsupra, Farxiga |
| Amgen INC. | $416.78 | 2025 | Repatha, Tavneos |
| Abbvie INC. | $335.04 | 2023-2024 | |
| Shield Therapeutics INC | $166.75 | 2023 | Accrufer |
| Phathom Pharmaceuticals, INC. | $123.36 | 2025 | Voquezna |
| Smith+Nephew, INC. | $120.79 | 2024 | Versajet, Collagenase Santyl |
| Hologic Sales and Service, LLC | $118.51 | 2025 | Aptima |
| Ars Pharmaceuticals Operations, INC. | $116.70 | 2025 | Neffy |
| Neurocrine Biosciences, INC. | $107.35 | 2024 | Ingrezza |
| Axsome Therapeutics, INC. | $104.58 | 2025 | Auvelity |
| Viiv Healthcare Company | $103.32 | 2025 | Dovato |
| Novo Nordisk INC | $100.80 | 2022 | |
| Boston Scientific Corporation | $98.55 | 2024 | Wavewriter Alpha Prime 16 |
| Gen-Probe, INC. | $97.01 | 2025 | Aptima |
| Coloplast Corp | $82.61 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $81.46 | 2021 | |
| Biogen, INC. | $40.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Passwaters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.